Gamma-aminobutyric acid type A receptor (GABA_A receptor) (GABA_A receptor)

The Gamma-aminobutyric acid type A (GABA_A) receptor is a pentameric ligand-gated chloride channel that serves as the primary mediator of fast inhibitory neurotransmission in the mammalian central nervous system (StatPearls, 2023). The diazepam-sensitive benzodiazepine (BZD) site is a specific allosteric binding pocket located at the interface of an alpha subunit (α1, α2, α3, or α5) and a gamma subunit (typically γ2) (Sigel & Steinmann, 2012). Binding of benzodiazepines to this site enhances the receptor's affinity for the endogenous neurotransmitter GABA, which increases the frequency of chloride channel opening and leads to hyperpolarization of the postsynaptic neuron (PubChem, 2024). This modulation results in a spectrum of pharmacological effects, including anxiolytic, sedative-hypnotic, anticonvulsant, and muscle relaxant activities (NIH, 2023). While these sites are critical therapeutic targets for managing acute anxiety and seizures, chronic drug interaction can lead to receptor downregulation, resulting in tolerance, physical dependence, and severe withdrawal symptoms upon discontinuation (FDA, 2020).

Other names

Benzodiazepine receptorBZD siteGABA-A receptorGABA(A) receptorLigand-gated chloride channelDiazepam-sensitive GABA receptorGABA_A receptor diazepam-sensitive benzodiazepine sites

Positive allosteric modulation of the GABA_A receptor, which increases the frequency of chloride channel opening in the presence of GABA, leading to increased chloride conductance and neuronal hyperpolarization.